Back to Connor, Clark & Lunn Investment Management Ltd. Connor, Clark & Lunn Investment Management Ltd.

GSKGSK
11 quarters

Position history for Connor, Clark & Lunn Investment Management Ltd.Connor, Clark & Lunn Investment Management Ltd.'s holdings in GSK PLC

Connor, Clark & Lunn Investment Management Ltd. holds 2.8M shares of GSK (GSK PLC), worth $145.1M as of 2026-Q2. The position was decreased (-1.8% shares). GSK represents 0.3% of Connor, Clark & Lunn Investment Management Ltd.'s portfolio.

Current Value

$145.1M

Current Shares

2.8M

Total Value Change

+$120.2M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.8M
-1.8%
$145.1M0.3%$51.95
0
2026-Q1
Increased
2.8M
+62.2%
$155.5M0.4%$54.20
53
2025-Q4
Increased
1.7M
+261.6%
$85.2M0.2%$47.78
57
2025-Q3
Increased
480,384
+392.2%
$20.7M0.1%$41.68
46
2025-Q2
Decreased
97,594
-57.7%
$3.7M0.0%$36.68
0
2025-Q1
Increased
230,561
+11.2%
$8.9M0.0%$36.58
31
2024-Q4
Decreased
207,374
-63.3%
$7M0.0%$31.59
0
2024-Q3
Increased
564,934
+420.1%
$23.1M0.1%$37.75
55
2024-Q2
New
108,615
-
$4.2M0.0%$35.22
37
2022-Q4
Exited
0
-100.0%
$00.0%$30.35
0
2022-Q3
New
845,924
-
$24.9M0.2%$25.18
47

Other major holders of GSK: FMR LLC, DODGE & COX

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used